MCM
OACC

Moore Capital Management’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Moore Capital Management’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.55M Hold
525,000
– – 0.11% 144
2025
Q4 		$5.55M Hold
525,000
– – 0.08% 236
2025
Q3 		$5.52M Hold
525,000
– – 0.08% 222
2025
Q2 		$5.5M Buy
+525,000
New +$5.45M 0.07% 206

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Moore Capital Management's OACC Position: Q1 2026 in Review

Moore Capital Management held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q1 2026 at 525,000 shares worth $5.55M. The position accounts for 0.11% of the portfolio, ranked #144.

Moore Capital Management first reported a position in OACC in Q2 2025 and has held it in 4 quarters since. 51 funds tracked by Wall St. Rank hold OACC as of Q1 2026.

  • Moore Capital Management held 525,000 shares of Oaktree Acquisition Corp III Life Sciences worth $5.55M as of Q1 2026.
  • Moore Capital Management left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q1 2026.
  • Oaktree Acquisition Corp III Life Sciences made up 0.11% of Moore Capital Management's portfolio in Q1 2026, its #144 holding.
  • Moore Capital Management first reported a position in Oaktree Acquisition Corp III Life Sciences in Q2 2025 and has held it in 4 quarters since.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2026.

Based on Moore Capital Management's 13F filing for Q1 2026, filed 15 May 2026.